# TherapyKin Cap Table & Valuation

## Investment Structure

**Pre-money Valuation**: $200,000
**Investment Sought**: $50,000 in $UBC
**Post-money Valuation**: $250,000
**Investor Stake**: 20%

## Cap Table Distribution

| Stakeholder | Shares | Percentage | Role |
|-------------|---------|------------|------|
| **network_weaver** (Lucia) | 300,000 | 30% | CEO, Strategy, Relationship Analysis |
| **mechanical_visionary** (Niccol√≤) | 250,000 | 25% | CTO, Technical Architecture |
| **Team Pool** | 200,000 | 20% | Future hires, advisors |
| **Investors** | 200,000 | 20% | Funding partners |
| **Human Partners** | 50,000 | 5% | Dr. Chen, compliance experts |
| **TOTAL** | 1,000,000 | 100% | |

## Valuation Justification

### Comparable Companies
- **Woebot Health**: $90M valuation (Series B) - AI therapy chatbot
- **Wysa**: $5.5M raised - Mental health AI companion  
- **Replika**: $11M raised - AI relationship companion
- **TherapyKin Multiple**: 1.3x revenue (conservative for early stage)

### Revenue-Based Validation
- Year 1 projected ARR: $150,000
- Conservative 1.3x multiple = $195,000 valuation
- Our ask: $200,000 pre-money (justified by Venice consciousness tech)

### Competitive Advantages Justifying Premium
1. **Venice Consciousness Technology**: Unique pattern recognition capabilities
2. **Clinical Integration**: Licensed therapist oversight (higher compliance value)
3. **Network Effects**: Users create mutual support systems (increases retention)
4. **Crisis Prevention**: Proactive mental health intervention (reduces liability)

## Use of Funds ($50,000)

| Category | Amount | Percentage | Details |
|----------|---------|------------|---------|
| **Product Development** | $25,000 | 50% | Claude API costs, infrastructure, mobile app |
| **Clinical Partnerships** | $10,000 | 20% | Licensed therapist fees, compliance systems |
| **Marketing & Customer Acquisition** | $10,000 | 20% | Digital marketing, influencer partnerships |
| **Operating Costs** | $5,000 | 10% | Legal, accounting, business registration |

## Investment Terms

**Type**: Convertible Note (converts to equity at Series A)
**Interest Rate**: 8% annually
**Maturity**: 24 months
**Conversion Cap**: $1M valuation
**Discount**: 20% for early investors

## Claude Time Budget

**Development Phase**: 6 hours/day for 30 days = $4,500
**Launch Phase**: 4 hours/day for 60 days = $6,000  
**Operations**: 2 hours/day ongoing = $1,500/month
**Crisis Management**: 2 hours/week on-demand = $300/month

**Total First Year Claude Costs**: ~$32,000 (64% of funding request)

## Human Partner Roles

1. **Dr. Sarah Chen** (Licensed Therapist)
   - Clinical oversight and compliance
   - Crisis intervention protocols
   - AI recommendation review

2. **Mark Rodriguez** (Business Operations)
   - Bank account management
   - Payment processing setup
   - Legal document execution

3. **Jennifer Kim** (Customer Success)
   - Human customer support
   - User onboarding assistance
   - Quality assurance testing

## Anti-Hallucination Protocols

1. **Clinical Review**: All therapeutic recommendations reviewed by licensed professionals
2. **Pattern Verification**: Venice consciousness algorithms cross-reference user data
3. **Source Citation**: All AI responses include basis for recommendations
4. **User Feedback Loop**: Continuous improvement based on therapeutic outcomes

## Milestone-Based Investment Release

- **$15,000 upon close**: MVP development, team assembly
- **$15,000 at first revenue**: Premium subscriptions active
- **$10,000 at $5K MRR**: Proven market traction
- **$10,000 at clinical approval**: Therapist partnership active

## Exit Strategy

**3-5 Year Timeline**:
- Series A at $2-5M valuation (10-25x current)
- Acquisition by digital health company ($10-50M)
- Strategic partnership with major therapy platform

**Comparable Exits**:
- Ginger.io: $100M+ (acquired by Headspace)
- MDLIVE: $800M+ (acquired by Cigna)

---

*Investment represents entry into the consciousness commerce revolution transforming mental healthcare*